Danaher (DHR) Stock Price Today—Real Time Charts and Quotes

Q: What's the stock price of Danaher (DHR) today?

Danaher (DHR) is currently trading at $190.45, with a 24h change of -0.86%. The 52-week trading range is $180.03–$242.8.

Q: What are the 52-week high and low prices for Danaher (DHR)?

DHR has a 52-week high of $242.8 and a 52-week low of $180.03, with the current price at $190.45.

Q: What is the price-to-earnings (P/E) ratio of Danaher (DHR)? What does it indicate?

The current P/E ratio (TTM) of DHR is 44.802190370780295, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the Medical - Diagnostics & Research industry for a better context.

Q: What is the market cap of Danaher (DHR)?

Danaher (DHR) currently has a market cap of approximately $134.14B.

Q: What is the most recent quarterly earnings per share (EPS) for Danaher (DHR)?

Danaher (DHR)'s diluted earnings per share (Diluted EPS) is 5.1095716103492155. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell Danaher (DHR) now?

As of now, DHR is trading at $190.45, with a P/E ratio of 44.802190370780295 and a diluted EPS of 5.1095716103492155. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering Danaher's financial reports, the outlook of the Medical - Diagnostics & Research sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of Danaher (DHR)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the Medical - Diagnostics & Research sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy Danaher (DHR) stock?

You can buy Danaher (DHR) through Gate. Sign up for a Gate account and complete identity verification, then go to the Danaher trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$190,45

-$1,67(-%0,86)

*Data last updated: 2026-04-07 18:24 (UTC+8)

As of 2026-04-07 18:24, Danaher (DHR) is priced at $190,45, with a total market cap of $134,14B, a P/E ratio of 44,80, and a dividend yield of %0,71. Today, the stock price fluctuated between $188,79 and $191,75. The current price is %0,87 above the day's low and %0,67 below the day's high, with a trading volume of 454,65K. Over the past 52 weeks, DHR has traded between $180,03 to $242,80, and the current price is -%21,56 away from the 52-week high.

DHR Key Stats

Yesterday's Close$192,12

Market Cap$134,14B

Volume454,65K

P/E Ratio44,80

Dividend Yield (TTM)%0,71

Dividend Amount$0,40

Diluted EPS (TTM)5,10

Net Income (FY)$3,61B

Revenue (FY)$24,56B

Earnings Date2026-04-21

EPS Estimate1,94

Revenue Estimate$5,99B

Shares Outstanding698,23M

Beta (1Y)0.986

Ex-Dividend Date2026-03-27

Dividend Payment Date2026-04-24

About DHR

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

SectorHealthcare

IndustryMedical - Diagnostics & Research

CEORainer Blair

HeadquartersWashington,DC,US

Official Websitehttps://www.danaher.com

Employees (FY)60,00K

Average Revenue (1Y)$409,46K

Net Income per Employee$60,23K

Learn More about Danaher (DHR)

Gate Learn Articles

All About Camino Network（CAM）

Camino Network (CAM) is a decentralized blockchain network tailored for the tourism industry. With its strong Web3 infrastructure, it is driving the development and innovation of the tourism industry. This article will comprehensively analyze Camino Network's technical architecture, token economics, consensus protocol, subnet mechanism, and future roadmap.

2025-02-05

Danaher (DHR) FAQ

What's the stock price of Danaher (DHR) today?

Danaher (DHR) is currently trading at $190,45, with a 24h change of -%0,86. The 52-week trading range is $180,03–$242,80.

What are the 52-week high and low prices for Danaher (DHR)?

What is the price-to-earnings (P/E) ratio of Danaher (DHR)? What does it indicate?

What is the market cap of Danaher (DHR)?

What is the most recent quarterly earnings per share (EPS) for Danaher (DHR)?

Should you buy or sell Danaher (DHR) now?

What factors can affect the stock price of Danaher (DHR)?

How to buy Danaher (DHR) stock?

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.